Press release
Radiopharmaceuticals Market Pharmaceuticals Industry to Accelerate at 9.0% CAGR during 2021 - 2028 | The Insight Partners
Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging, Bayer AG, Bracco Imaging, Eczacýbaþý-Monrol Nuclear Products, Nordion, Advanced Accelerator Applications, and NTP Radioisotopes are among leading companies operating in the radiopharmaceuticals market.
Download PDF Sample of Radiopharmaceuticals Market with Insights @ https://www.theinsightpartners.com/sample/TIPRE00003751/?utm_source=OpenPR&utm_medium=10291
Scope of Radiopharmaceuticals Market:
The growth of the radiopharmaceuticals market is primarily attributed to the rising prevalence of chronic diseases.
Suitability of alpha radioimmunotherapy in targeted cancer treatment.
Advancements in nuclear imaging techniques.
However, short shelf-life of radiopharmaceuticals and availability of substitutes hinder the market growth.
Segmentation:
Based on type, the radiopharmaceuticals market is bifurcated into diagnostic nuclear medicine and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is holding a larger share of the market and is expected to register a higher CAGR during the forecast period. The market growth for this segmented can be attributed to the availability of diagnostic devices and ease offered by these devices for the diagnosis of various disorders. Moreover, increasing incidence of cardiac diseases, cancer, and neurological disorders is expected to fuel the demand for better diagnosis of these disorders. Radiopharmaceuticals provide better diagnostic information about the functioning of a specific organ, as it uses radiation.
Product Type-Based Insights
Based on product type, the radiopharmaceuticals market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and other. The Technetium-99m segment is holding the largest share of the market, whereas the gallium-67 segment is expected to register the highest CAGR during 2021–2028.
Application-Based Insights
Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, neurology, and others. The oncology segment is holding the largest share of the market. The market growth for this segment can be attributed to the increasing incidence of cancer worldwide. Cancer is one of the significant health problems with a high mortality rate.
Interested In Purchasing This Report? Click Here @ https://www.theinsightpartners.com/sample/TIPRE00003751/?utm_source=OpenPR&utm_medium=10291
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Pharmaceuticals Industry to Accelerate at 9.0% CAGR during 2021 - 2028 | The Insight Partners here
News-ID: 2366590 • Views: …
More Releases from The Insight Partners
Calcium Carbide Industry Advances with Strategic Expansions, Sustainable Innovat …
The Calcium Carbide Industry is experiencing a period of strategic evolution, driven by robust industrial demand, technological innovation, and regulatory shifts shaping production and applications across global markets. As a critical industrial chemical, calcium carbide continues to play an indispensable role in sectors such as metallurgy, chemicals, welding, and infrastructure development, with recent developments underscoring the industry's dynamic growth trajectory.
Check valuable insights in the Calcium Carbide Market report. You can…
Cytiva Pioneers Next-Generation Chromatography Resin Advancements for Biopharma …
United States of America - January 09, 2025 - According to The Insight Partners, The Chromatography Resin Market size is expected to reach US$ 4,224 million by 2031. The market is anticipated to register a CAGR of 7.3% during 2025-2031. Cytiva (Danaher Corporation) today announced breakthrough innovations in chromatography resin technology, designed to streamline purification processes for pharmaceutical and biotechnology companies worldwide. This development addresses key challenges in bioprocessing, enhancing…
Cardiopulmonary Exercise Testing Market Poised for Steady Expansion Through 2031 …
United States of America - January 09, 2025 - According to The Insight Partners, The Cardiopulmonary Exercise Testing Market is expected to register a CAGR of 7.33% from 2025 to 2031. The Cardiopulmonary Exercise Testing market continues to gain momentum as healthcare providers worldwide prioritize advanced diagnostic tools for cardiovascular and pulmonary conditions. This non-invasive testing method, often referred to as cardiopulmonary exercise testing (CPET), evaluates heart and lung performance…
Global Medical Robots Market Poised for Transformational Growth Through 2033
The Medical Robots Market continues to redefine modern healthcare delivery, driven by rapid technological advancements, expansion of minimally invasive surgical procedures, and growing adoption of autonomous support systems in clinical settings. As medical robotics technology evolves, the industry is experiencing heightened interest from hospitals, surgical centers, and healthcare innovators seeking to improve precision, reduce errors and transform patient outcomes.
Recent industry developments - including expanded robotics research units and novel product…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to…
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
